title: [Molecular genetics of hemochromatosis].
abstract: Hemochromatosis is a recessive disorder of iron metabolism characterized by progressive iron loading of parenchymal organs, which accounts for clinical complications such as cirrhosis, diabetes mellitus, cardiopathy, endocrine dysfunctions and arthropathy. Clinical complications, which usually develop after the third or fourth decade of life, can be fatal but may be prevented by phlebotomy if iron excess is detected at a very early stage. The hemochromatosis gene (HFE), located 4.5 megabases telomeric to the HLA-A locus, encodes an HLA class I like protein and two missense mutations, C282Y and H63D in complete disequilibrium have been identified within this gene. Due to its high frequency in the general population, the involvement of H63D in the pathogenesis of the disease remains controversial, and it might correspond to a minor mutation. Conversely, the C282Y mutation is tightly linked to the disease, as it accounts for 80 to 100% of the hemochromatosis cases in Northern Europe. The lower frequency observed, in the patients, in Italy and South of France led to imagine either the implication of other mutations or of other genes. The C282Y mutation is absent in Asia and Africa and is present in the general population with a decreasing gradient of frequency from Northern to Southern Europe. The prevalence of the disease was usually estimated to be 3% but the observed frequency of the C282Y homozygotes is 5% in our breton population raising the question of the penetrance of the disease, and consequently the use of the genotypic test for its systematic screening. As HFE encodes a membrane protein similar to HLA class I protein, its contribution to iron overload is not obvious. The normal protein is predicted to to be expressed at the cell surface in association with beta 2-microglobulin, a localization for which C282Y is critical as it disrupts this association. This protein has also been shown to form a stable complex with the transferrin receptor leading to a decreased affinity for transferrin. A better knowledge of its function will help to decipher iron and different metal-ions metabolism. Although the exact role of the HFE protein is unknown, the genotypic test allows the clinicians to ascertain their diagnosis and genetic counselling.
authors.affiliation: UPR 41 CNRS, Faculté de Médecine, Rennes, France.
authors.forename: V
authors.initials: V
authors.lastname: David
authors.forename: A M
authors.initials: AM
authors.lastname: Jouanolle
authors.forename: P
authors.initials: P
authors.lastname: Fergelot
authors.forename: P
authors.initials: P
authors.lastname: Brissot
authors.forename: Y
authors.initials: Y
authors.lastname: Deugnier
authors.forename: J Y
authors.initials: JY
authors.lastname: Le Gall
mesh_terms: D005805:Genes, MHC Class I; D005808:Genes, Recessive; D006432:Hemochromatosis / Q000453:epidemiology / Q000235:genetics* / Q000503:physiopathology; D006801:Humans; D009154:Mutation